The US FDA expects that as part of a product development Design Control Program risk management will be conducted. FDA also expects a post production risk management program be implemented.
FDA recommends using ISO 14971 as a guide and has accepted it as a recognized standard.
One of the techniques described in ISO 14971 is Hazard Analysis. This is the most powerful of the risk management techniques because it considers risks in normal operation as well as fault conditions. FMEA and FTA consider only fault conditions and are more suited as reliability tools than as product safety tools.
The following areas will be covered during the session:
- Detailed process of conducting a hazard analysis
- The confusing terms “hazard”, hazardous situation”, “harm”, “causative event”, “ALARP”, “risk index”, “benefit/ risk ratio”, and “residual risk” will be explained
- We will go step by step through a template for risk analysis so that the process is clear
- Examples of hazards and hazardous situations will be discussed.
- How to deal with residual risk will be discussed.
- We will explain how to integrate Human Factors studies into the Hazard Analysis.
- How to integrate Hazard Analysis into the design program.
- Application of ISO 14971 principles to software risk management will be explained
Why should you attend?
FDA expects that as part of a product development program risk management will be conducted and risks will be mitigated as far as practical. Risk Analysis is required in a FDA product submission. FDA recommends using ISO 14971 as a guide and has accepted it as a recognized standard.
Hazard Analysis is the most powerful of the risk management tools described in ISO 14971 but it is very confusing. Many new concepts are introduced. We will explain these concepts and provide examples so that the process is clear.
Handouts are hazard analysis forms and HA report template
Who will benefit?
- Engineer management
- Quality assurance
- Regulatory Professionals
Edwin Waldbusser is a consultant retired from industry after 20 years in management of development of medical devices (5 patents). He has been consulting in the US and internationally in the areas of design control, risk analysis and software validation for the past 11 years.
Mr. Waldbusser has a BS in Mechanical Engineering and an MBA. He is a Lloyds of London certified ISO 9000 Lead Auditor and a member of the Thomson Reuters Expert Witness network.